Abstract

BackgroundThe intubating laryngeal mask Fastrach™ is considered a gold standard for blind intubation as well as for fibreoptic guided intubation via a laryngeal mask. Recently, a single use version of the mask has been introduced. We compared the Fastrach single use with the new, low-priced single use intubating laryngeal mask Ambu Aura-i™.We hypothesised that the LMA Ambu Aura-i and the LMA Fastrach are comparable with respect to success rates for mask placement and blind tracheal intubation through the LMA device.MethodsA prospective, randomised clinical trial. University Hospital Schleswig-Holstein, Campus Kiel, from April 2011 to April 2012.Eighty patients undergoing general anaesthesia with planned tracheal intubation were randomised and enrolled in the study. Blind intubation was performed with either laryngeal mask using two different tracheal tubes (Rüsch Super Safety Silk™ and LMA ETT™). A crossover-design was performed after an unsuccessful procedure.Primary outcome measure was the overall success rate of blind intubation. Secondary outcome measures were the time to the first adequate ventilation, a subjective handling score, and a fibreoptic control of placement, as well as the success rate of mask placement, time for mask removal after successful intubation, differences in airway leak pressure, and the incidence of postoperative sore throat and hoarseness.ResultsThe success rate of tracheal intubation with the Fastrach for the first and second attempt was significantly better compared with the Ambu Aura-i. Tracheal intubation was also significantly faster (14.1 s. ±4.4 versus 21.3 s. ±9.0; p < 0.01), and the time interval for mask removal after successful intubation was significantly shorter using the Fastrach device (24.0 s. ±8.2 versus 29.4 s. ±7.5; p < 0.001). There were no significant differences between groups regarding the incidence of postoperative sore throat and hoarseness.ConclusionBoth laryngeal mask devices are suitable for ventilation and oxygenation. Blind intubation remains the domain of the LMA Fastrach, the Ambu Aura-i is not suitable for blind intubation.Trial registrationClinicaltrials.gov Identification Number NCT03109678, retrospectively registered on April 12, 2017.

Highlights

  • The intubating laryngeal mask FastrachTM is considered a gold standard for blind intubation as well as for fibreoptic guided intubation via a laryngeal mask

  • We investigated the feasibility of blind intubation using the laryngeal masks (LMA) Ambu Aura-i and compared it with the LMA Fastrach as contemporary reference

  • We hypothesised that the LMA Ambu Aura-i and the LMA Fastrach are comparable with respect to success rates for mask placement and tracheal intubation

Read more

Summary

Introduction

The intubating laryngeal mask FastrachTM is considered a gold standard for blind intubation as well as for fibreoptic guided intubation via a laryngeal mask. We compared the Fastrach single use with the new, low-priced single use intubating laryngeal mask Ambu Aura-iTM. We hypothesised that the LMA Ambu Aura-i and the LMA Fastrach are comparable with respect to success rates for mask placement and blind tracheal intubation through the LMA device. With reported rates for successful intubation of 75% on the first attempt, and 99,7% with fibreoptic assistance [3, 4], LMA Fastrach became the reference for LMA assisted tracheal intubation. Similar and lower-priced intubating LMAs have been developed, such as the LMA Ambu Aura-iTM. We investigated the feasibility of blind intubation using the LMA Ambu Aura-i and compared it with the LMA Fastrach as contemporary reference

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call